206 related articles for article (PubMed ID: 7166751)
41. Activation of human monocytes for nitroblue tetrazolium reduction and the suppression of lymphocyte response to mitogens.
Zembala M; Lemmel EM; Uracz W
Clin Exp Immunol; 1980 Aug; 41(2):309-16. PubMed ID: 7438557
[TBL] [Abstract][Full Text] [Related]
42. Monocyte functional defects in rheumatoid arthritis.
Jiménez López A; Olmos Martínez JM; García Palomo JD; De Dios Martín B; Pedraz García MJ; Lorente Toledano F
Allergol Immunopathol (Madr); 1982; 10(5):353-9. PubMed ID: 6762081
[TBL] [Abstract][Full Text] [Related]
43. Alteration in monocyte function in patients with breast cancer.
Al-Sumidaie AM; Leinster SJ; Webster DJ; Jenkins SA
Eur J Surg Oncol; 1987 Oct; 13(5):419-24. PubMed ID: 3666157
[TBL] [Abstract][Full Text] [Related]
44. Bestatin treatment of human lymphocytes increases the frequency of sheep red blood cell-binding cells.
Blomgren H; Wasserman J
Cancer Lett; 1981 Feb; 11(4):303-8. PubMed ID: 7296523
[TBL] [Abstract][Full Text] [Related]
45. The effect of an oral therapeutic single dose of doxycycline on subsequent monocyte phagocytosis in vitro.
Athlin L; Domellöf L; Norberg B
Acta Chir Scand; 1986 Jan; 152():9-13. PubMed ID: 3953226
[TBL] [Abstract][Full Text] [Related]
46. Neutrophil and monocyte phagocytic functions in patients with colorectal adenocarcinoma during fluorouracil therapy.
Lukac J; Kusić Z; Kovacević D; Soldić Z; Troskot B
Anticancer Res; 1995; 15(6B):2805-9. PubMed ID: 8669869
[TBL] [Abstract][Full Text] [Related]
47. Bestatin treatment enhances the recovery of radiation induced impairments of the immunological reactivity of the blood lymphocyte population in bladder cancer patients.
Blomgren H; Edsmyr F; von Stedingk LV; Wasserman J
Biomed Pharmacother; 1986; 40(2):50-4. PubMed ID: 3756312
[TBL] [Abstract][Full Text] [Related]
48. Interferon enhances NBT-reduction and phagocytosis by human monocytes.
Jarstrand C; Einhorn S
J Clin Lab Immunol; 1981 Nov; 6(3):211-4. PubMed ID: 6175753
[No Abstract] [Full Text] [Related]
49. Monocyte locomotion in anergic chronic brucellosis patients: the in vivo effect of ascorbic acid.
Boura P; Tsapas G; Papadopoulou A; Magoula I; Kountouras G
Immunopharmacol Immunotoxicol; 1989; 11(1):119-29. PubMed ID: 2760414
[TBL] [Abstract][Full Text] [Related]
50. Influence of tumor necrosis factor-alpha on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro.
Muniz-Junqueira MI; dos Santos-Neto LL; Tosta CE
Cell Immunol; 2001 Mar; 208(2):73-9. PubMed ID: 11333139
[TBL] [Abstract][Full Text] [Related]
51. Thymostimulin administration modulates polymorph metabolic pathway in patients with chronic obstructive pulmonary disease.
Tortorella C; Ottolenghi A; Moretti AM; Jirillo E; Antonaci S
Immunopharmacol Immunotoxicol; 1992; 14(3):421-37. PubMed ID: 1325490
[TBL] [Abstract][Full Text] [Related]
52. Enhancement of defective monocyte function during immunotherapy with recombinant interferon.
Nielsen H; Ernst P
Cancer Immunol Immunother; 1986; 22(2):144-7. PubMed ID: 3719594
[TBL] [Abstract][Full Text] [Related]
53. Induction of DNA polymerase alpha and terminal deoxynucleotidyl transferase in the human lymphoblastoid cell line Molt-4 by the immunomodulator bestatin.
Leyhausen G; Dippold W; Zahn RK; Meyer zum Büschenfelde KH; Umezawa H; Müller WE
Immunopharmacology; 1984 Jun; 7(3-4):151-7. PubMed ID: 6590537
[TBL] [Abstract][Full Text] [Related]
54. The effect of colorectal malignancies on monocyte migration, lysozyme production, and phagocytosis.
Al-Sumidaie AM; Copeland GP; Leinster SJ; Jenkins SA
Eur J Surg Oncol; 1986 Dec; 12(4):367-71. PubMed ID: 3780990
[TBL] [Abstract][Full Text] [Related]
55. [Augmentation of the phagocytic activity of monocytes in patients with Darier's disease by the oral administration of retinoic acid].
Laguens M; Ranalletta MA
Med Cutan Ibero Lat Am; 1987; 15(5):407-10. PubMed ID: 3325709
[TBL] [Abstract][Full Text] [Related]
56. Ticlopidine administration to patients does not inhibit the ability of their monocytes to form rosettes and to phagocytize erythrocytes in vitro.
Cimminiello C; Bernasconi P; Chianese R; Uberti T; Pietra A; Gibelli A
Int J Tissue React; 1987; 9(3):251-3. PubMed ID: 3596966
[TBL] [Abstract][Full Text] [Related]
57. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity.
Inoi K; Goto S; Nomura S; Isobe K; Nawa A; Okamoto T; Tomoda Y
Anticancer Res; 1995; 15(5B):2081-7. PubMed ID: 8572606
[TBL] [Abstract][Full Text] [Related]
58. Altered monocyte functions in patients with angioimmunoblastic lymphadenopathy.
Pálóczi K; Zeher M; Lukács K; Kávai M; Szegedi G
Haematologia (Budap); 1987; 20(2):109-15. PubMed ID: 3653789
[TBL] [Abstract][Full Text] [Related]
59. Effects of pravastatin on the in vitro phagocytic function and hydrogen peroxide production by monocytes of healthy individuals.
Muniz-Junqueira MI; Karnib SR; de Paula-Coelho VN; Junqueira LF
Int Immunopharmacol; 2006 Jan; 6(1):53-60. PubMed ID: 16332513
[TBL] [Abstract][Full Text] [Related]
60. Inhibitory effects of ubenimex (bestatin) on the invasion of uterine cervical carcinoma cells and their production and activation of gelatinase A.
Ueda M; Ueki M; Fujii H; Yoshizawa K; Nakajima M
J Med; 1997; 28(3-4):175-90. PubMed ID: 9355022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
